ライフサイエンスコーパス: cervix

1 t of placebo (fibroid protruding through the cervix).

2 have had a hysterectomy with removal of the cervix.

3 ted women was calculated and compared to the cervix.

4 d, persistent, or recurrent carcinoma of the cervix.

5 lium, normally found near the more posterior cervix.

6 cervical squamocolumnar (SC) junction of the cervix.

7 be different for different locations in the cervix.

8 ines as well as in carcinomas of the uterine cervix.

9 found in more than 70% of carcinomas of the cervix.

10 type 16 (HPV16), cause cancer of the uterine cervix.

11 single-shot DW echo-planar MR imaging of the cervix.

12 lva, vagina, urethra, ovary, and the uterine cervix.

13 )Cu-ATSM in women with cancer of the uterine cervix.

14 ident oncogenic HPV infection of the uterine cervix.

15 integrated HPV-16 DNA compared to the normal cervix.

16 16 DNA compared to both C-33A and the normal cervix.

17 s and precancerous conditions of the uterine cervix.

18 8 and associated precancerous lesions at the cervix.

19 s for locally advanced cancer of the uterine cervix.

20 review of 152 patients with carcinoma of the cervix.

21 ent and acute visceral pain from the uterine cervix.

22 for benign disease and they no longer have a cervix.

23 or recurrent squamous cell carcinoma of the cervix.

24 ose that predominate in the cognate maternal cervix.

25 ions and advanced squamous carcinomas of the cervix.

26 n papillomavirus oncogenesis of the skin and cervix.

27 ge of LPS from the uterine horns through the cervix.

28 GO) stage IB3 squamous cell carcinoma of the cervix.

29 ting continued trafficking of T cells to the cervix.

30 the model using two injections distal to the cervix.

31 and background DNA controls, but not of the cervix.

32 t commonly infect the oropharynx and uterine cervix.

33 ular mechanisms that govern PG action in the cervix.

34 ntly infected animals inoculated only in the cervix.

35 m birth in patients with a short sonographic cervix.

36 0.0001), kidney (1.25, 1.17-1.33; p<0.0001), cervix (1.10, 1.03-1.17; p=0.00035), thyroid (1.09, 1.00

37 ectum (1.13), liver (1.47), lung (1.17), and cervix (1.52), as well as acute myeloid leukemia (AML, 1

38 DNA in cervical tissue specimens with normal cervix (20 cases), cervical intraepithelial neoplasia (C

39 ositivity was less common for cancers of the cervix (3.3%), vagina (8.3%), vulva (1.5%), and penis (8

40 n-Hodgkin lymphoma [11.51, 11.14-11.89], and cervix [3.24, 2.94-3.56]), most other virus-related canc

41 interval [CI], 4.9%-79.1%) was comparable to cervix (45.8%; 95% CI, 6.4%-69.4%).

42 both the anal canal (13.2% of women) and the cervix (5.1%).

43 liver (73%), kidney (>70%), bile duct (57%), cervix (50%), and, to a lesser extent, additional cancer

44 (62.0%, 95% CI 47.1-73.1) compared with the cervix (76.4%, 67.0-83.5; p for interaction by anatomica

45 n with singleton pregnancies who had a short cervix, a cervical pessary did not result in a lower rat

46 of the lungs, head and neck, oesophagus, and cervix account for up to 30% of cancer deaths, the mecha

47 confirm the absence of residual tumor in the cervix after a cone biopsy with negative margins.

48 e second most frequent cancer of the uterine cervix after squamous carcinoma, and the most frequent h

49 (HPV) infection among women was 42.7% in the cervix and 3.8% in the oral cavity.

50 se phenotypes (M1 and M2) are present in the cervix and are most likely involved in the postpartum re

51 detection of monotypic sequences across the cervix and blood, especially during effective ART, sugge

52 However HIV-1 levels within the cervix and breast milk were not associated with CMV with

53 d CD4 counts were associated with CMV in the cervix and breast milk.

54 Of 166 miRNAs expressed in normal cervix and cancer cell lines, we observed significant ex

55 noncontiguous cervical biopsies or from the cervix and circulating PBMC in seven of eight subjects.

56 vical infection model in which we bypass the cervix and directly inoculate C. trachomatis into the ut

57 allopian tubes and endometrium), followed by cervix and ectocervix.

58 ding fallopian tube, gastrointestinal tract, cervix and endometriosis.

59 mited to patients with cancer of the uterine cervix and for patients with ovarian cancer.

60 We used Policy1-Cervix and HPV-ADVISE-two dynamic models of HPV transmis

61 with M. genitalium strain G37 in the uterine cervix and in salpingeal pockets generated by transplant

62 ests (NAAT) for Chlamydia trachomatis at the cervix and in urine was examined in 3,551 women, and the

63 risk factors for vulvar HPV were similar to cervix and included: age (adjusted odds ratio [aOR] 0.5

64 iruses homing to and/or expanding within the cervix and is rarely due to unique viruses evolving with

65 n, and this pain originates from the uterine cervix and is transmitted via the hypogastric nerve to t

66 dules for the ovary, fallopian tube, uterus, cervix and liver, with a sustained circulating flow betw

67 P expression is very low or absent in normal cervix and LSILs, is readily detectable in HSILs, and is

68 st, head and neck, colon, prostate, bladder, cervix and lung, and has been related to disease progres

69 e naturally deposited at the entrance to the cervix and must swim through viscoelastic cervical mucus

70 n average 3 and 8 years before diagnosis for cervix and noncervix cancers, respectively) and 718 matc

71 development of squamous cell cancers of the cervix and of the head and neck.

72 be repressed in HPV-positive cancers of the cervix and oropharynx is miR-424.

73 enic types of HPV (HPV 16 and HPV 18) at the cervix and other anatomical sites at which HPV-related c

74 The rate of new HPV detection at the cervix and penis were 33.83 events/1000 person-months (9

75 t details unique mechanisms of action in the cervix and serves as a catalyst for (i) the use of 15-PG

76 in dysplasias and squamous carcinomas of the cervix and skin.

77 pression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40

78 d to determine the SWE values of the healthy cervix and the agreement levels between radiologists.

79 t MR imaging of the subglandular and stromal cervix and the difference between both were correlated t

80 cancer and its precursor lesions in both the cervix and the vagina.

81 of mammals, including the oviducts, uterus, cervix and upper vagina, are derived from the Mullerian

82 and increased leukocyte infiltration in the cervix and uterus compared to AZ2.

83 Specifically, HA depletion in the cervix and vagina resulted in inappropriate differentiat

84 in the female lower reproductive tracts (ie, cervix and vagina) in the human papillomavirus transgeni

85 inflammatory responses to infection in both cervix and vagina, recruits CD4(+) T cells to fuel this

86 t 18-24 weeks (31.2%) and those with a short cervix and vaginal bleeding in the first half of pregnan

87 urine and those in cellular sampling of the cervix and vulva, and their correlation with rigorously

88 nse inflammatory infiltrate was found in the cervix and vulva.

89 have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade pre

90 that could limit chlamydial infection to the cervix and/or prevent reinfection inform vaccine approac

91 r of the head and neck, oesophagus, stomach, cervix, and bladder.

92 n cancers of the ovary, lung, head and neck, cervix, and BRCA1 positive and basal breast cancers.

93 imarily as a nuclear protein in skin, normal cervix, and cervical cancer tissues, but not in larynx.

94 ved in fallopian tubes, uterine endometrium, cervix, and ectocervix.

95 system, ovaries, pancreas, stomach, uterus, cervix, and endometrium).

96 colon and rectum, stomach, prostate, liver, cervix, and esophagus-the most important risk factors, c

97 ther surface epithelia, including epidermis, cervix, and esophagus.

98 nancies, especially cancers of the GI tract, cervix, and head and neck.

99 ined nitric oxide (NO) concentrations in the cervix, and high NO levels are related to carcinogenesis

100 Cancers of the breast, uterine cervix, and lip or oral cavity are three of the most com

101 me, poor knowledge about the location of the cervix, and not knowing that a vaccine could prevent cer

102 ins, including colon, breast, lung, stomach, cervix, and ovary, and demonstrate DNA hypermethylation

103 ression on CD4+ T cells isolated from blood, cervix, and rectum of IA markers including CD38 and HLA-

104 n self-renewing epithelium of the intestine, cervix, and skin.

105 imary human keratinocytes from the foreskin, cervix, and tonsils.

106 ew cell populations in the breast, prostate, cervix, and upper reproductive tract-are shared by embry

107 Compartmentalization of viruses within the cervix appears in part due to viruses homing to and/or e

108 ost frequently associated with cancer of the cervix are now available.

109 chanisms of this paradoxical function of the cervix are unknown.

110 activated organisms were inoculated into the cervix at any time interval.

111 with C. muridarum cleared infection at their cervix at the same rate as wild-type (WT) mice, but were

112 Leukocytes infiltrate the cervix before and after birth and are proposed to regula

113 e monocytes and eosinophils increased in the cervix before birth in a progesterone-regulated fashion,

114 s- and gain-of-function experiments in human cervix, breast, and pancreatic cancer cells.

115 es localized inflammation of the urethra and cervix by inducing production of IL-1beta and other infl

116 cyte and cytokine environment induced in the cervix by seminal fluid appears competent to initiate ad

117 nvolved in the pathogenesis of cancer of the cervix (CaCx).

118 ated from regions over the placenta (PAM) or cervix (CAM) and examined the effect of cyclic tensile s

119 reported that VHR is upregulated in several cervix cancer cell lines as well as in carcinomas of the

120 he inhibitors decreased the proliferation of cervix cancer cells, while growth of primary normal kera

121 ons and exhibit antiproliferative effects on cervix cancer cells.

122 of DNA double strand breaks (DSBs), in human cervix cancer HeLa and osteoblast-like MG-63 cells.

123 fe Questionnaire Core 30 (EORTC QLQ-C30) the cervix cancer module and chemotherapy and neuropathy sub

124 Patients with locally advanced cervix cancer were randomly assigned to CIS chemoradioth

125 VAC) or topotecan plus cisplatin in advanced cervix cancer, we undertook a randomized trial comparing

126 (CIS) chemoradiotherapy in locally advanced cervix cancer.

127 splatin was the drug of choice in metastatic cervix cancer.

128 ant treatment failure still seen in advanced cervix cancer.

129 be an important prognostic tool in advanced cervix cancer.

130 hemotherapy over cisplatin alone in advanced cervix cancer.

131 microbe itself, as in Burkitt's lymphoma and cervix cancer.

132 is the standard of care for locally advanced cervix cancer; the optimal chemotherapy regimen is not y

133 d HPV45 account for approximately 20% of all cervix cancers.

134 sidered unrelated to treatment) and placebo (cervix carcinoma and colon adenoma) groups.

135 ve in the cytotoxicity assay using the human cervix carcinoma cell line KB-3-1 and its multidrug-resi

136 /necrosis ratio in breast adenocarcinoma and cervix carcinoma cells.

137 human prostate cancer cells but not in HeLa cervix carcinoma cells.

138 on, an increase in lipid levels, and in situ cervix carcinoma treated by conization.

139 established A431 epidermoid carcinoma, C33a cervix carcinoma, and LS174T colorectal adenocarcinoma.

140 er TNF-alpha and IL-1beta in T cell, B cell, cervix carcinoma, hepatoma, breast cancer, and astrocyto

141 erapy for advanced, recurrent, or metastatic cervix carcinoma.

142 stent infection in high-passage-number human cervix cells (HeLa-H cells; passages 170 to 221) but not

143 to 221) but not in low-passage-number human cervix cells (HeLa-L cells; passages 95 to 115) or in se

144 strongly with (i) presence of HPV DNA at the cervix (chi2 = 68.8; P < .0001), (ii) multiple types of

145 e compared samples from three groups: normal cervix, CIN 2/3 from immunocompetent women (HIV- CIN 2/3

146 1) the Callascope's ability to visualize the cervix compared to the standard-of-care speculum exam, (

147 significantly alters the biochemistry of the cervix, compared with women who have not had treatment;

148 Western-blotting on mouse cervix confirmed large scale histone de-acetylation in l

149 mphoma (5.7%)--and in females--cancer of the cervix (constituting 23.3% of all cancers in females) an

150 very enables satisfactory administration and cervix coverage.

151 an epithelial endometrium-derived HEC-1B and cervix-derived HeLa cells, seeded and polarized on colla

152 of a Shirodkar suture in women with a short cervix does not substantially reduce the risk of early p

153 the first time, that viral infection of the cervix during pregnancy reduces the capacity of the fema

154 w for maximal compliance and dilation of the cervix during the birth process.

155 s, larynx, lung, soft tissue, female breast, cervix, endometrial, prostate, testes, eye and orbit, br

156 advanced, or metastatic cancer of the ovary, cervix, endometrium, bladder, prostate, oesophagus, squa

157 ALT in carcinomas arising from the bladder, cervix, endometrium, esophagus, gallbladder, kidney, liv

158 esented for carcinomas of the anus, bladder, cervix, endometrium, ovary, penis, prostate, rectum, tes

159 s studied (stomach, biliary tract, pancreas, cervix, endometrium, prostate, kidney, bladder, and lymp

160 5 pretreatment (18)F-FDG PET images (breast, cervix, esophageal, head and neck, and lung cancer tumor

161 hree sites (anorectum, pharynx, and urethral/cervix) every four months using self-collected swabs.

162 ngth varies amongst women, the percentage of cervix excised may correlate more accurately to risk tha

163 ion that localizes to the SC junction of the cervix, expresses a unique gene expression signature, an

164 of surgery, (18)F-FDG was injected into the cervix, followed by an immediate dynamic PET/CT scan of

165 effector CD8 + T cells were detected in the cervix following systemic administration of ChAdOx1-5GHP

166 m samples obtained from different locations (cervix, fornix, outer vaginal canal) and by different me

167 ks (RR 3.96 95% CI [1.04-15.05]) and a short cervix from 18-24 weeks (RR 4.52 95% CI [1.08-19.01]) co

168 erve as a cutoff value to distinguish normal cervix from CIN and from CIN to CC.

169 Serum progesterone profiles, myometrium and cervix function, and mitochondrial electron transport ch

170 characteristic features are empty uterus and cervix, gestational sac in the anterior part of lower ut

171 epithelium and underlying stroma from normal cervix, graded CINs, cancer, and patient-matched normal

172 igh-grade lesions and cancers of the uterine cervix harbor integrated HPV genomes expressing the E6 a

173 o investigate whether, in women with a short cervix identified by routine transvaginal scanning at 22

174 e anal canal in 148 women (47.6%) and in the cervix in 82 (26.4%).

175 nd tissue distensibility was observed in the cervix in both models.

176 It is recognized that a short cervix in mid-pregnancy is associated with an increased

177 We hypothesized that a long cervix in mid-pregnancy would be associated with an incr

178 e and cytokine parameters occur in the human cervix in response to the male partner's seminal fluid.

179 Similarly, nulliparous women with a short cervix in the second trimester require further explorati

180 ous acquistion of FP/HW Raman signals of the cervix in vivo within 1 s.

181 infection, whereas prior coinfections in the cervix increased risk of a new cervical HPV infection.

182 esponses at the maternal-fetal interface and cervix induced by T cell activation.

183 maRIIb receptor in the epithelium lining the cervix initiate expression of genes that block recruitme

184 In maternal epithelial tissues (thyroid, cervix, intestine, and gallbladder), 14% to 60% of XY+ c

185 rom the epidermis, oropharynx, esophagus and cervix into genetically defined tumors in a human three-

186 The uterine cervix is a hormone-responsive tissue, and female hormon

187 apparent diffusion coefficient (ADC) of the cervix is associated with preterm delivery in asymptomat

188 The cervix is central to the female genital tract immune res

189 The proinflammatory cytokine milieu in the cervix is enhanced in pregnant women with bacterial vagi

190 plementation for assessing the tissue of the cervix is evolving, and SWE analyses of healthy, nonpreg

191 analgesia initiated early in labor (when the cervix is less than 4.0 cm dilated) has been associated

192 The uterine cervix is the boundary structure between the uterus and

193 ng, and SWE analyses of healthy, nonpregnant cervixes is the first step in understanding other SWE ch

194 uamous epithelia of human esophagus, tonsil, cervix, larynx, and cornea.

195 progression in an analysis of primary normal cervix, low grade squamous intraepithelial lesions, high

196 cervical tissue specimens, including normal cervix, low-grade squamous intraepithelial lesions (LSIL

197 onal age, 26 weeks) with a sonographic short cervix (</=15 mm) underwent pelvic 1.5-T magnetic resona

198 above quartile 3 (14.3%), women with a short cervix (<25 mm) at 18-24 weeks (31.2%) and those with a

199 d in at least six distinct cancers: bladder, cervix, lung (adenocarcinoma and squamous cell carcinoma

200 is in human cancers including breast, colon, cervix, lung and pancreas.

201 er cell lines (from prostate, brain, kidney, cervix, lung, colon, liver, and breast tumors).

202 or types, such as carcinomas of the bladder, cervix, lung, head/neck, and breast.

203 Altered local levels in the cervix may influence an individual's immune response, th

204 HIV-susceptible CD4(+) T cell subsets in the cervix may provide a mechanism for the increased HIV sus

205 the microbiota of the lower FRT (vagina and cervix) microenvironment is dominated by Lactobacillus s

206 a double-stranded DNA tumor virus infecting cervix, mouth, and throat tissues.

207 ervention, women destined to develop a short cervix (n = 36) exhibited higher cervico-vaginal concent

208 CSF-1 in cervical tumor (n = 17) and normal cervix (n = 8) samples.

209 nancies (n=642) and carcinoma of the uterine cervix (n=336).

210 malignancies (1.6%) were found: vulva (n=6), cervix (n=5), and anus (n=5).

211 be detected in the vulva/vagina than in the cervix (odds ratio, 4.38 [95% confidence interval, 2.51-

212 on a comparative transcriptomic study of the cervix of four placental mammals, mouse, guinea pig, rab

213 grade dysplasia and cancer that arose in the cervix of K14E6/E7 transgenic mice treated long-term wit

214 0-silk sutures sub-paramarginally around the cervix of right-left mandibular first molars and maintai

215 was induced by placing ligatures around the cervix of the maxillary second molars for 21 days.

216 lized nylon (000) thread ligature around the cervix of the second left upper molar of the animals, wh

217 is injected interstitially into the uterine cervix on the day of surgery, and its rapid transport th

218 of concordant incident HPV infections of the cervix or anus following infection at the other anatomic

219 AUS$35.99 (80% UI 28.47-41.18) with Policy1-Cervix or AUS$22.74 (15.49-34.45) with HPV-ADVISE, at a

220 rradiated region) abnormal FDG uptake in the cervix or lymph nodes in 20 patients.

221 es, PTB, or late miscarriage; previous short cervix or short cervix this pregnancy; or uterine abnorm

222 and a traditional sample (obtained from the cervix or urethra), and used an appropriate reference st

223 fection characterized by inflammation of the cervix or urethra.

224 test samples are obtained directly from the cervix or urethra.

225 ained on samples collected directly from the cervix or urethra.

226 ts with squamous cell carcinoma (SCC) of the cervix or vulva have limited therapeutic options, and th

227 terectomy and hysterectomies that spared the cervix or were performed for cervical neoplasia, we esti

228 OR 1.83; 95% CI 1.34-2.49; p = 1.31 x 10-4), cervix (OR 1.55; 95% CI 1.27-1.88; p = 1.24 x 10-5), and

229 in lymph nodes but not the ovaries, uterus, cervix, or vagina in FP isolate-infected dams.

230 colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and chi

231 t patients with small-cell carcinomas of the cervix, ovary, uterus, vagina, and vulva.

232 anoma, and 64 pelvic malignancies (prostate, cervix, penis, vulva).

233 malies and aneuploidy; examining the uterus, cervix, placenta, and amniotic fluid; and guiding obstet

234 ull mouse, and clearly demonstrated that the cervix plays a key role in their delayed parturition.

235 veloped for coding these elements in breast, cervix, prostate, and colon cancers, and combining them

236 nclear whether a pessary inserted around the cervix reduces the risk of preterm singleton birth.

237 dation statement applies to women who have a cervix, regardless of sexual history.

238 linical implications of these viruses at the cervix remain to be determined.

239 Carcinoma of the cervix remains a significant health problem for women wo

240 The cervix represents a formidable structural barrier for su

241 studying processes such as wound healing and cervix ripening.

242 01) in the SCCs relative to HSILs and normal cervix samples.

243 for advanced squamous cell carcinomas of the cervix, SCCA1 has also been found to be associated with

244 e aimed to target the consistency of healthy cervix shear wave elastography measurements and examine

245 If the cervix shortened (<25 mm) before 24 weeks' gestation, wo

246 l hrHPV and promoter hypermethylation in the cervix show promise as biomarkers for anal cancer screen

247 Squamous carcinomas of the cervix, skin, esophagus, and head and neck exhibited the

248 dually had similar infection kinetics in the cervix, SP6, the virulent variant, could be isolated fro

249 prominent path for lactate uptake by a human cervix squamous carcinoma cell line that preferentially

250 sessment of Cancer Therapy-General (FACT-G), Cervix subscale (Cx subscale), FACT/GOG-Neurotoxicity su

251 mber of viral target cells in the vagina and cervix, suggesting that the ratio of target cells to ant

252 1,453 msec +/- 123; T2, 59 msec +/- 1), and cervix (T1, 1,616 msec +/- 61; T2, 83 msec +/- 7).

253 infections, two-site (anorectum and urethra/cervix) testing identified 92-100% of C. trachomatis or

254 etically engineered mice that express in the cervix the HPV16 early region genes implicated as causat

255 At term, fetal membranes overlying the cervix, the future site of rupture, show altered morphol

256 mor's origin to either the uterine corpus or cervix, the odds of the tumor originating from that site

257 quency of activated HIV targets cells at the cervix, the site of initial HIV entry in most women, pro

258 c HPV infection, compared with WNH without a cervix, they have minimal risk of HPV-induced cancer and

259 miscarriage; previous short cervix or short cervix this pregnancy; or uterine abnormality and/or cur

260 due to differences in susceptibility of the cervix to infection by virus during pregnancy and the as

261 induced in the physiological response of the cervix to seminal fluid in vivo.

262 tissues, we compared viruses from across the cervix to those in peripheral blood mononuclear cells (P

263 ively validated simulation platform, Policy1-Cervix, to do a dynamic multicohort modelled analysis of

264 the Functional Assessment of Cancer Therapy-Cervix Trial Outcome Index (FACT-Cx TOI).

265 trophoblast retrieval and isolation from the cervix (TRIC).

266 , EA) and posterior (IP, EP) portions of the cervix using a transvaginal approach in eight postmenopa

267 rvical cancer, the malignant neoplasm of the cervix uteri is the second most common cancer among wome

268 rectum, anus, liver, pancreas, lung, breast, cervix uteri, and prostate) comprising 60% of global dia

269 detected in the blood, lymph nodes, vagina, cervix, uterus, and fallopian tubes.

270 creased inflammatory mediators on E17 in the cervix, uterus, and fetal membranes but not in the place

271 nostic factor in small-cell carcinoma of the cervix, uterus, and ovary.

272 otype-specific concordance suggests that the cervix (vagina) and anus may serve as reservoirs for HPV

273 Following analysis of primary cervix, vagina, and first-void female urine specimens fo

274 erectomy and compared them with those of the cervix, vagina, rectum, oral cavity, and controls for ba

275 Cervix visualization was comparable between the Callasco

276 (especially type 16) can cause cancer of the cervix, vulva, vagina, anus, penis, and oropharynx.

277 The cervix was 15 mm or less in 470, and 253 (54%) of these

278 On evaluation with a vaginal speculum, her cervix was found to have been replaced by a friable lesi

279 a diagnosis of adenocarcinoma of the uterine cervix was subjected to chemotherapy after radical surge

280 Policy1-Cervix was used to estimate the lifetime risk of cervica

281 esults and the presence of EBV or CMV in the cervix, we did find a high prevalence of both viruses: 2

282 y 26 of the 35 HPV types found to infect the cervix were also found within the oral cavity, and the t

283 he bacterial profiles of the endometrium and cervix were dominated by Acinetobacter, Pseudomonas, Clo

284 ntially found in the lower tract (vagina and cervix), whereas APCs and innate lymphoid cells were mai

285 s and cancers of the skin, breast, lung, and cervix, whereas the effects are much less pronounced in

286 re protected from ascending infection by the cervix, which controls and limits microbial access by th

287 uamous intraepithelial lesions (HSIL) of the cervix will progress to invasive squamous cell carcinoma

288 on (WHO) recommends visual inspection of the cervix with acetic acid (VIA) as cervical cancer screeni

289 egies incorporating visual inspection of the cervix with acetic acid or DNA testing for HPV in one or

290 strategy involving visual inspection of the cervix with acetic acid or DNA testing for human papillo

291 We inoculated 45 female macaques in the cervix with Chlamydia trachomatis once weekly for 5 week

292 ked inflammatory cervical infiltrates in the cervix with enrichment of HIV target cells.

293 necologic exam revealed a 3-cm barrel-shaped cervix with friability at the os and no appreciable para

294 6.2-cm mass extending from the uterus to the cervix with greater than 50% myometrial invasion (MMI; F

295 among women with a previous infection at the cervix with HPV of the same genotype.

296 or recurrent or persistent carcinoma of the cervix with measurable disease and GOG performance statu

297 carcinoma, or adenosquamous carcinoma of the cervix, with an Eastern Cooperative Oncology Group perfo

298 tongue, esophagus, forestomach, and uterine cervix within just 10 to 20 days.

299 , enabling clinician and self-imaging of the cervix without the need for a speculum.

300 PTB rates in women with a sonographic short cervix, yet there has been little investigation into the